investors.taminco.com
Taminco Investor Relations - Corporate Profile
Taminco at a Glance. Submit your Invention, Idea or Solution. Dec 5, 2014. Eastman Completes Acquisition of Taminco. Nov 6, 2014. Taminco Corporation Announces Third Quarter 2014 Results. Oct 27, 2014. Taminco Corporation Announces Third Quarter 2014 Earnings Release Date and Conference Call. No events to display. Taminco Corporation Q3 2014 Earnings Presentation - November 6, 2014. Taminco Corporation Quarterly Income Statement - Q4. Annual Meeting and Proxy Materials. Tweets by @taminco 1.
investors.tangeroutlet.com
Tanger Outlets | Investor Relations | Corporate Profile
Atlantic City, New Jersey. Blowing Rock, North Carolina. Charleston, South Carolina. Deer Park, New York. Fort Myers, Florida. Hilton Head, South Carolina. Lincoln City, Oregon. Locust Grove, Georgia. Mebane, North Carolina. Myrtle Beach - Hwy 17, SC. Myrtle Beach - Hwy 501, SC. Nags Head, North Carolina. Ocean City, Maryland. Park City, Utah. Rehoboth Beach, Delaware. Riverhead, New York. San Marcos, Texas. Tilton, New Hampshire. West Branch, Michigan. Wisconsin Dells, Wisconsin. Myrtle Beach - Hwy 17.
investors.target.com
Investors | Investor Contacts, News, Stocks & Events | | Target Corporate
Skip to main navigation. A Bullseye View. Behind the scenes at Target. MBAs and graduate degrees. News and features expand. News and features home. Target embraces innovation to drive strong financial performance and create new opportunities for profitable growth. 160; 0.56. Dividend and stock split history. Statement from Brian Cornell Regarding Kathee Tesija Transition. CVS Health and Target Sign Agreement for CVS Health to Acquire, Rebrand and Operate Target’s Pharmacies and Clinics.
investors.targovax.com
Investor Relations | Targovax
Skip to main content. Adenovirus-based cancer immunotherapies: ONCOS-102, ONCOS-402. Peptide-based targeted immunotherapies: TG01, TG02 and TG03. Listing on the Oslo Axess. Subscribe to our news. Targovax is an innovation driven specialist in immuno-oncology. Immunotherapy is a fast growing segment within the biotech market, estimated by analysts to reach some USD 35 billion by 2023. Targovax at Redeye’s Fight Cancer event 20th of September:. Listing on the Oslo Axess. Phone: 47 21 39 88 10.
investors.taubman.com
Q4 Web Site Development
Q4 Web Maintenance Message. This site is currently under development and not yet available for public viewing. For more information on why this site is not available, please contact Q4.
investors.taylormorrison.com
Taylor Morrison (NYSE - TMHC) Investor Relations - Investors
Previous Close $20.10. 52 Week High $21.40. 52 Week Low $14.96. Taylor Morrison Reports Second Quarter Revenue of $701 Million and Adjusted Earnings per Share of $0.33. Taylor Morrison has been helping families create memories for more than a century. We are proud to instill this deep heritage into every new home we build, helping to make us one of the leading homebuilders in the United States. Our long-term strategy is built upon the following FOUR PILLARS. Culture of Strong Cost Efficiency. Data provid...
investors.tdsinc.com
TDS - Investor Relations - Investor Relations Home
Stock and Debt Information. Publicly Traded Retail Debt. Share Consolidation and Reclassification. Annual Reports and Proxy Statements. Investor Info and Contacts. Board Committees and Charters. Officer and Director Code of Conduct. Restated Certificate of Incorporation. California Transparency in Supply Chains Act Disclosure. We provide outstanding communication services to our customers and meet the needs of our shareholders, our people and our communities. Stock and Debt Information.
investors.te.com
TE Connectivity - Investor Home
Go to TE.com. March 29, 2018. TE Connectivity releases over 25,000 new digital models in collaboration with SnapEDA. TE Connectivity to Participate in Morgan Stanley Technology, Media and Telecom Conference. TE Connectivity named among World's Most Ethical Companies by Ethisphere Institute. Q1 2018 TE Connectivity Ltd. Earnings Conference Call. Q118 Presentation (PDF 621 KB. Click Here to Email. Transfer Agent/Shareholder Services page. Berwyn, PA 19312. TE Connectivity Main Switchboard:.
investors.tecnoglass.com
Investor Relations - Tecnoglass, Inc.
History - time line. POWDER COATING - WOOD GRAIN FINISH. Annual Reports and Proxies. Financial Superintendence of Colombia. The Company is a leading manufacturer of a variety of architectural glass, windows, and associated aluminum products for the global residential and commercial construction industries. The Company sells to more than 300 customers in North, Central and South America, and exports approximately 43% of its production to foreign countries, with the United States accounting for approximate...
investors.tegel.co.nz
Home
Latest News and Announcements. Annual and Interim Reports. Presentations and Investor Updates. Latest News and Announcements. Annual and Interim Reports. Presentations and Investor Updates. 15:25, 13 January 2017. Tegel is New Zealand's market leading poultry producer, and has been part of New Zealanders' lives since 1961. The company is involved in breeding, hatching, processing, marketing, sales and distribution of poultry products across New Zealand and to selected international markets. Dec 15, 2016.
investors.tegna.com
Tegna | Investor Relations | Corporate Overview
Our People and Culture. Tax Basis Information for Gannett Spin-Off. TEGNA Media Honored with Eight 2015 Salute to Excellence Awards from NABJ. TEGNA Announces Quarterly Dividend. TEGNA to sell McLean, VA headquarters to Tamares. Q2 2015 TEGNA Inc. Earnings Conference Call. You may also find news of interest to investors on our News Releases. Vice President, Investor Relations. 7950 Jones Branch Dr. McLean, VA 22107. Wells Fargo Shareowner Services. PO Box 64854,. St Paul, MN 55164-0854.
SOCIAL ENGAGEMENT